Edmund (Ed) Vanderbeck joins XGen Pharmaceuticals DJB, Inc.

On May 4, 2020, Ed Vanderbeck joined XGen Pharmaceuticals DJB, Inc. as President, becoming only the third person to fill the position since the founding of Pharma-Tek almost 50 years ago.  Ed joins XGen DJB as a proven pharmaceutical industry leader having spent the last twelve years of his career with Chemwerth, Inc., a full [...]

read more

The Release of Folic Acid Injection, USP

XGen Pharmaceuticals DJB, Inc. announced today it will begin marketing and distributing Folic Acid Injection, USP.  Folic Acid Injection, USP is a sterile non pyrogenic solution of sodium folate (prepared by the addition of sodium hydroxide to folic acid) in Water for Injection, USP intended for intramuscular (IM), intravenous (IV) or subcutaneous (SC) use. Folic [...]

read more

The Relaunch of Ibuprofen Lysine

Big Flats NY - XGen Pharmaceuticals DJB Inc. announced today the relaunch of Ibuprofen Lysine injection.  Ibprofen Lysine injection is therapeutically equivalent to Recordati Rare Diseases’ NeoProfen® Injection.Ibuprofen Lysine Injection is indicated to close a clinically significant patent ductus arteriosus (PDA), an abnormal opening between the aorta and the pulmonary artery. Ibuprofen Lysine treats premature infants [...]

read more

The Release of Dactinomycin for Injection, USP

Big Flats, NY., August 1st, 2019 – X-GEN Pharmaceuticals announced today the immediate availability in the United States of Dactinomycin for Injection, USP. Dactinomycin is an actinomycin indicated for the treatment of: • adult and pediatric patients with Wilms tumor, as part of a multi-phase, combination chemotherapy regimen. • adult and pediatric patients with rhabdomyosarcoma, [...]

read more

X-GEN Pharmaceuticals Begins Marketing and Distributing Piperacillin and Tazobactam for Injection

Big Flats, NY, March 1, 2017 – X-GEN Pharmaceuticals announced today it will begin marketing and distributing Piperacillin and Tazobactam for Injection. X-GEN’s Piperacillin and Tazobactam for Injection is a combination penicillin-class antibacterial and β-lactamase inhibitor indicated for the treatment of various bacterial infections. The medical community has been plagued by shortages and inconsistencies in [...]

read more

X-GEN Pharmaceuticals receives first generic FDA approval for Lincomycin Injection, USP

Big Flats, NY, February 1, 2016 - X-GEN Pharmaceuticals, Inc. becomes the first generic alternative to receive FDA approval of their ANDA for the marketing and distribution of Lincomycin Injection, USP. Lincomycin is used to treat serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci when penicillin is inappropriate due to patient allergies [...]

read more

X-GEN Pharmaceuticals, Inc. Begins Supplying Magnesium Sulfate

Big Flats, NY, March 2, 2015 - X-GEN Pharmaceuticals announces availability of Magnesium Sulfate Injection, USP. Healthcare systems around the U.S are experiencing a shortage of Magnesium Sulfate, which is a critical component in Total Parenteral Nutrition (TPN), supplying vital nutrients to patients who need IV nutrition to stay alive. It also is indicated as [...]

read more

X-GEN Pharmaceuticals, Inc. Begins Marketing Nystatin Topical

Big Flats, NY, September 26, 2014 - X-GEN Pharmaceuticals, Inc. announced today that it is re-launching Nystatin Topical Powder USP, a generic product AT rated to Mycostatin®. Nystatin Topical Powder is an antibiotic used to treat skin infections caused by a wide variety of yeasts. X-GEN received FDA approval for Nystatin Topical in December of [...]

read more


XGen Pharmaceuticals DJB
300 Daniel Zenker Drive
Big Flats, NY 14814

+1 (866) 390-4411